NUsurface Implant Registry
TerminatedNCT03953846
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this active post-market surveillance clinical registry study is to further characterize the therapeutic effect, the long-term safety and effectiveness of the NUsurface® meniscus implant in the real-world post-marketing setting
Study details
- Official title
- A Long-term Non-interventional Registry Study to Assess the Effectiveness and Safety of the NUsurface® Meniscus Implant
- Conditions
- Meniscus
- Degeneration
- Knee Osteoarthritis
- Knee Pain Chronic
- Sponsor
- Phoenix Kinetics
- Start date
- 2019-06-01
- Primary completion
- 2023-11-01
- Sex
- All
- Age range
- from 18 Years to 70 Years
- Results posted
- No results posted in this snapshot
- Countries
- Belgium, Germany, Israel, Netherlands
- Total sites listed
- 6
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * New or current treatment with the NUsurface® meniscus implant * Evidence of a personally signed and dated informed consent document indicating that the subject (or a legally acceptable representative) has been informed of all pertinent aspects of the Registry. Exclusion Criteria: * There are no protocol exclusion criteria; all subjects who meet the inclusion criteria are eligible for enrollment.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03953846